Sunday, May 24, 2026

#Catalyst Pharmaceuticals

124 articles

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Jul 11, 2023

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Jun 27, 2023

PAVmed And PAVmed On The List Of Winners And Losers Of Wednesday's US Session

PAVmed And PAVmed On The List Of Winners And Losers Of Wednesday's US Session

ViaNews Editorial Team•Jun 21, 2023

Catalyst Pharmaceuticals Stock Bearish By 31% In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Bearish By 31% In The Last 21 Sessions

ViaNews Editorial Team•Jun 8, 2023

Catalyst Pharmaceuticals Stock Slides By 29% In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Slides By 29% In The Last 21 Sessions

ViaNews Editorial Team•Jun 6, 2023

Catalyst Pharmaceuticals Stock Over 30% Down In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Over 30% Down In The Last 21 Sessions

ViaNews Editorial Team•Jun 5, 2023

Catalyst Pharmaceuticals Stock Bearish Momentum With A 31% Fall In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Bearish Momentum With A 31% Fall In The Last 21 Sessions

ViaNews Editorial Team•Jun 2, 2023

Catalyst Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Jun 2, 2023

Catalyst Pharmaceuticals Stock Went Down By Over 27% In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Went Down By Over 27% In The Last 21 Sessions

ViaNews Editorial Team•May 30, 2023

Catalyst Pharmaceuticals Stock Is 27% Down In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Is 27% Down In The Last 21 Sessions

ViaNews Editorial Team•May 29, 2023

Catalyst Pharmaceuticals Stock Over 31% Down In The Last 10 Sessions

Catalyst Pharmaceuticals Stock Over 31% Down In The Last 10 Sessions

ViaNews Editorial Team•May 24, 2023

Catalyst Pharmaceuticals Stock Went Down By Over 28% In The Last 10 Sessions

Catalyst Pharmaceuticals Stock Went Down By Over 28% In The Last 10 Sessions

ViaNews Editorial Team•May 23, 2023

Catalyst Pharmaceuticals Stock Bearish Momentum With A 29% Drop In The Last 10 Sessions

Catalyst Pharmaceuticals Stock Bearish Momentum With A 29% Drop In The Last 10 Sessions

ViaNews Editorial Team•May 19, 2023

Catalyst Pharmaceuticals Stock Bearish By 30% In The Last 21 Sessions

Catalyst Pharmaceuticals Stock Bearish By 30% In The Last 21 Sessions

ViaNews Editorial Team•May 16, 2023

Catalyst Pharmaceuticals Stock Impressive Fall 15% So Far On Thursday, Underperforms Market

Catalyst Pharmaceuticals Stock Impressive Fall 15% So Far On Thursday, Underperforms Market

ViaNews Editorial Team•May 11, 2023

Catalyst Pharmaceuticals And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Apr 17, 2023

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Apr 14, 2023

Catalyst Pharmaceuticals Stock Jumps By 15% In The Last 5 Sessions

Catalyst Pharmaceuticals Stock Jumps By 15% In The Last 5 Sessions

ViaNews Editorial Team•Mar 22, 2023

Catalyst Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Catalyst Pharmaceuticals And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

ViaNews Editorial Team•Mar 21, 2023

Catalyst Pharmaceuticals Stock Was Up By 9.55% On Thursday

Catalyst Pharmaceuticals Stock Was Up By 9.55% On Thursday

ViaNews Editorial Team•Mar 16, 2023